Log In
BCIQ
Print this Print this
 

CINtec Cytology Kit

  Manage Alerts
Collapse Summary General Information
Company Roche
DescriptionImmunocytochemistry assay for detection of the p16INK4a antigen in cervical cytology preparations
Molecular Target Cyclin dependent kinase inhibitor 2A (CDKN2A) (INK4a) (ARF) (p16INK4a)
Mechanism of ActionDiagnostic
Therapeutic ModalityDiagnostics
Latest Stage of DevelopmentMarketed
Standard IndicationCancer, Diagnostic
Indication DetailsDetect pre-cancerous cervical lesions to help identify women with underlying high-grade cervical intraepithelial lesions
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

1

$266.6M

$182.6M

$84.0M


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone

09/05/2011

$266.6M

$182.6M

$84.0M

Get a free BioCentury trial today